anti-glycogen synthase 2 siRNA (Dicerna Pharmaceutical)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanti-glycogen synthase 2 siRNA (Dicerna Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionGlycogen synthase 1 inhibitors
TargetsGlycogen synthase 1
Therapy Area/IndicationsGlycogen Storage Disease Type IIIGlycogen Storage Disease Type I
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDicerna Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDicerna Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGlycogen Storage Disease Type IIIGlycogen Storage Disease Type I

Other Information

ATC CodeN/A
Related LinksN/A